According to Cardinal Health's research, 76% of rheumatologists are "very familiar" with biosimilars, up from 53% in the 2020 report, and 62% are "very comfortable" prescribing biosimilars, compared to 41% in the 2020 report.
Several pharmacy groups have filed a joint amicus brief stating that the Oklahoma Patient’s Right to Pharmacy Choice Act addresses a subset of the business practices of PBMs.
Furosemide injection is a diuretic indicated for parenteral therapy for patients unable to take oral medications or for patients in emergency clinical situations.
The booster shot is authorized for people 18 and older who, for medical or accessibility reasons, cannot take one of the bivalent messenger RNA COVID-19 boosters.